CIK 0001631574 · Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Moran Kyle Chief Financial Officer | Sale 10b5-1 | −50,000 | $13.20 | $660K | 89,218 |
| 2025-12-08 | Moran Kyle Chief Financial Officer | Option exercise 10b5-1 | +50,000 | $4.75 | $238K | 139,218 |
| 2025-12-08 | Moran Kyle Chief Financial Officer | Sale 10b5-1 | −50,000 | $18.00 | $900K | 89,218 |
| 2025-12-08 | Moran Kyle Chief Financial Officer | Grant or award · Share Option (right to buy) 10b5-1 | −60,000 | 0 | ||
| 2025-12-08 | Moran Kyle Chief Financial Officer | Grant or award · Share Option (right to buy) 10b5-1 | −100,000 | 75,000 | ||
| 2025-12-08 | Moran Kyle Chief Financial Officer | Grant or award · Share Option (right to buy) 10b5-1 | −50,000 | 222,700 | ||
| 2025-12-08 | CORRIGAN MARK Director | Sale 10b5-1 | −9,600 | $13.09 | $126K | 35,330 |
| 2025-12-08 | CORRIGAN MARK Director | Sale 10b5-1 | −6,515 | $14.07 | $92K | 28,815 |
| 2025-11-13 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,000 | $6.69 | $7K | 18,203,009 |
| 2025-11-13 | Rawcliffe Adrian Director | Sale 10b5-1 | −16,115 | $6.79 | $109K | 12,700 |
| 2025-08-22 | Verdine Gregory L. Director | Sale 10b5-1 | −10,000 | $10.00 | $100K | 285,217 |
| 2025-08-22 | BOLNO PAUL President and CEO | Sale 10b5-1 | −217,351 | $10.10 | $2.2M | 121,000 |
| 2025-08-15 | Tan Aik Na Director | Option exercise 10b5-1 | +21,000 | $9.13 | $192K | 61,388 |
| 2025-08-15 | Tan Aik Na Director | Sale 10b5-1 | −21,000 | $9.25 | $194K | 40,388 |
| 2025-08-15 | Tan Aik Na Director | Option exercise · Share Option (right to buy) 10b5-1 | −21,000 | 0 | ||
| 2025-08-13 | HENRY CHRISTIAN O Director | Sale 10b5-1 | −9,670 | $8.81 | $85K | 29,645 |
| 2025-08-11 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +12,700 | 28,815 | ||
| 2025-08-11 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Share Option (Right to Buy) | +76,200 | 76,200 | ||
| 2025-08-11 | CORRIGAN MARK Director | Grant or award | +12,700 | 44,930 | ||
| 2025-08-11 | CORRIGAN MARK Director | Grant or award · Share Option (right to buy) | +76,200 | 76,200 |
Page 7 of 13 · 255 trades